ALB and hereditary elliptocytosis: A European survey on use of albumin in cirrhosis suggested that albumin was mainly employed for preventing PPCD and renal failure and treating type-1 HRS, ascites, non-SBP bacterial infections, severe hyponatremia (<125mmol/L), HE, and hypoalbuminemia [35].